# Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons

> **NCT02538952** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 18696 (actual)

## Conditions studied

- Tuberculosis
- Human Immunodeficiency Virus

## Interventions

- **DEVICE:** Xpert device
- **OTHER:** Intensified TB Case Finding (ICF)

## Key facts

- **NCT ID:** NCT02538952
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-01
- **Primary completion:** 2017-07-01
- **Final completion:** 2017-07-01
- **Target enrollment:** 18696 (ACTUAL)
- **Last updated:** 2019-06-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538952, "Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02538952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*